KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Amortizatization of Intangibles (2017 - 2024)

Guardant Health's Amortizatization of Intangibles history spans 8 years, with the latest figure at $4.0 million for Q4 2024.

  • For Q4 2024, Amortizatization of Intangibles rose 50.02% year-over-year to $4.0 million; the TTM value through Dec 2024 reached $6.8 million, down 50.01%, while the annual FY2025 figure was $5.9 million, 13.24% down from the prior year.
  • Amortizatization of Intangibles for Q4 2024 was $4.0 million at Guardant Health, up from $2.9 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $7.8 million in Q3 2023 and bottomed at -$3.3 million in Q4 2021.
  • The 5-year median for Amortizatization of Intangibles is -$528000.0 (2020), against an average of -$56700.0.
  • The largest annual shift saw Amortizatization of Intangibles plummeted 766.67% in 2020 before it soared 1703.69% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$2.4 million in 2020, then plummeted by 38.78% to -$3.3 million in 2021, then surged by 62.79% to -$1.2 million in 2022, then soared by 314.73% to $2.6 million in 2023, then skyrocketed by 50.02% to $4.0 million in 2024.
  • Per Business Quant, the three most recent readings for GH's Amortizatization of Intangibles are $4.0 million (Q4 2024), $2.9 million (Q3 2024), and $4000.0 (Q2 2024).